| RS1465829182 |
DNMT3A
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1465836003 |
TPM2
|
Health Risk |
Pathogenic |
Arthrogryposis, distal |
| RS146583835 |
SMAD9
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary arterial hypertension associated with congenital heart disease, Pulmonary arterial hypertension associated with congenital heart disease |
| RS146583950 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146584228 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hyperinsulinism, Transitory neonatal diabetes mellitus |
| RS1465842300 |
SLC12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter syndrome, Inborn genetic diseases |
| RS146584570 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS146584765 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS146584956 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Hereditary spastic paraplegia |
| RS146586939 |
CHSY1
|
Health Risk |
Conflicting classifications of pathogenicity |
Temtamy preaxial brachydactyly syndrome, Temtamy preaxial brachydactyly syndrome |
| RS146586991 |
MCPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 1, primary |
| RS146587089 |
CACNA2D2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, CACNA2D2-related disorder |
| RS1465872803 |
CSF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS146587686 |
SEC23B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia, type II |
| RS146588335 |
EVC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS146588336 |
INSR
|
Health Risk |
Conflicting classifications of pathogenicity |
Insulin-resistant diabetes mellitus AND acanthosis nigricans, Rabson-Mendenhall syndrome |
| RS146588608 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2N, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS146588811 |
CDHR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 15, Cone-rod dystrophy 15 |
| RS146588926 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS146589465 |
ATG7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1465903121 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS146591309 |
PDE6A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS146591738 |
FLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS146591828 |
ALPK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1465921700 |
FOXE3
|
Health Risk |
Pathogenic |
Congenital primary aphakia, Anterior segment dysgenesis |
| RS146592584 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS146592828 |
FYCO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 18, FYCO1-related disorder |
| RS146593015 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypercholesterolemia |
| RS1465930949 |
VMA21
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked myopathy with excessive autophagy, Inborn genetic diseases |
| RS146593865 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS146594275 |
WDR87
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146594802 |
CDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 3 |
| RS146595129 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 17, Joubert syndrome 17 |
| RS146595460 |
CES1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146596574 |
SERPINA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha-1-antitrypsin deficiency, Alpha-1-antitrypsin deficiency |
| RS146596670 |
CEP55
|
Health Risk |
Pathogenic/Likely pathogenic |
Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome, Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome |
| RS1465966933 |
LRPPRC
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS146597866 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS146598030 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 14 |
| RS1465980897 |
CA4
|
Health Risk |
Likely pathogenic |
— |
| RS1465984343 |
TOE1
|
Health Risk |
Pathogenic |
— |
| RS1465993279 |
ARSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS146599698 |
ATP5MK
|
Health Risk |
Pathogenic |
Mitochondrial complex 5 (ATP synthase) deficiency, nuclear type 6 |
| RS146599917 |
PLEKHG2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146600671 |
BTD
|
Health Risk |
Conflicting classifications of pathogenicity |
Biotinidase deficiency, Biotinidase deficiency |
| RS146600721 |
TSPEAR
|
Health Risk |
Likely pathogenic |
— |
| RS1466009259 |
FLAD1
|
Health Risk |
Pathogenic |
— |
| RS146601260 |
STAMBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly-capillary malformation syndrome, Microcephaly-capillary malformation syndrome |
| RS146601335 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory neuropathy-deafness-dementia syndrome, Inborn genetic diseases |
| RS146601373 |
ERCC4
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group F |
| RS146601680 |
TWNK
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146603801 |
ALG8
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG8 congenital disorder of glycosylation, ALG8-related disorder |
| RS146603886 |
MCEE
|
Health Risk |
Likely pathogenic |
Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency, Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency |
| RS1466044046 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS146604807 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146604877 |
SALL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Duane-radial ray syndrome |
| RS1466053170 |
UNC80
|
Health Risk |
Likely pathogenic |
— |
| RS1466053365 |
CRPPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2U, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS146605798 |
NBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Microcephaly |
| RS146606352 |
GNAT2
|
Health Risk |
Likely pathogenic |
Achromatopsia 4, Achromatopsia 4 |
| RS1466067357 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS146606931 |
NLRP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoinflammatory syndrome, Cryopyrin associated periodic syndrome |
| RS1466073004 |
HPS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS146608591 |
SLC6A19
|
Health Risk |
Likely pathogenic |
Neutral 1 amino acid transport defect, Neutral 1 amino acid transport defect |
| RS146608896 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS146609069 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Spermatogenic failure 28 |
| RS1466102804 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS146610448 |
TECRL
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 3 |
| RS146610900 |
DPAGT1
|
Health Risk |
Conflicting classifications of pathogenicity |
DPAGT1-congenital disorder of glycosylation, Congenital myasthenic syndrome 13 |
| RS146611034 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Monosomy 7 myelodysplasia and leukemia syndrome 1, SAMD9L-related disorder |
| RS1466111134 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS146611494 |
ZNF804A
|
Health Risk |
Conflicting classifications of pathogenicity |
ZNF804A-related disorder, ZNF804A-related disorder |
| RS1466115591 |
OPA3
|
Health Risk |
Likely pathogenic |
3-Methylglutaconic aciduria type 3, 3-Methylglutaconic aciduria type 3 |
| RS146611729 |
UNC13D
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 3, Inborn genetic diseases |
| RS146612279 |
FN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1466129143 |
SCN2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1466129760 |
CSDE1
|
Health Risk |
Pathogenic |
— |
| RS1466130502 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Spastic paraplegia |
| RS146613648 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with C3 anomaly, Age related macular degeneration 9 |
| RS146614144 |
PDGFRB
|
Health Risk |
Conflicting classifications of pathogenicity |
Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome, Infantile myofibromatosis |
| RS1466149546 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS146614981 |
FXYD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal hypomagnesemia 2, FXYD2-related disorder |
| RS146615166 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1466153326 |
LTBP4
|
Health Risk |
Likely pathogenic |
— |
| RS146615936 |
IFT172
|
Health Risk |
Conflicting classifications of pathogenicity |
Short-rib thoracic dysplasia 10 with or without polydactyly, Retinitis pigmentosa 71 |
| RS146616224 |
COQ8B
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephrotic syndrome, type 9 |
| RS146616621 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, NEB-related disorder |
| RS1466167635 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS146617004 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS146617205 |
THRB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146617227 |
BBS7
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 7 |
| RS1466172660 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS146617683 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial dilated cardiomyopathy, Palmoplantar blistering |
| RS1466182533 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1466185247 |
RAD51C
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS146618526 |
IARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome, Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome |
| RS1466186480 |
ITGB2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Leukocyte adhesion deficiency 1 |
| RS146618661 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146618994 |
AR
|
Health Risk |
Conflicting classifications of pathogenicity |
Androgen resistance syndrome, Kennedy disease |
| RS146619272 |
TEX15
|
Health Risk |
Conflicting classifications of pathogenicity |
Spermatogenic failure 25, Spermatogenic failure 25 |